Early vs late switch to an intravitreal Dexamethasone implant after failed Anti-VEGF therapy for diabetic macular edema: A systematic review and meta-analysis
{{output}}
Introduction: Monthly anti-vascular endothelial growth factors (VEGF) are the primary line of management of diabetic macular edema (DME). However, a large number of patients do not respond to anti-VEGF and require Dexamethasone i... ...
